Pharmapace Acquired By WuXi AppTec
socalTECH
MAY 6, 2019
Financial details of the acquisition were not announced. WuXi AppTec said that Pharmapace will become a wholly owned subsidiary of its clinical CRO arm, WuXi Clinical, as a result of the acquisition.
Let's personalize your content